Evidence map›Paper›PMID 33591641›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia.

Takeshi Fujiwara, Satoshi Hoshide, Naoko Tomitani, Hao-Min Cheng, Arieska Ann Soenarta, Yuda Turana, Chen-Huan Chen, Huynh Van Minh, Guru Prasad Sogunuru, Jam Chin Tay and 6 more

Open access · diamondAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 9 countries.

Takeshi FujiwaraDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0003-4151-2806
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0001-7541-5751
Naoko TomitaniDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0002-1443-7073
Hao-Min ChengDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0002-3885-6600
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia.
Yuda TuranaFaculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0003-4527-0285
Chen-Huan ChenDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0002-9262-0287
Huynh Van MinhDepartment of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam.ORCID 0000-0003-4273-4187
Guru Prasad SogunuruDepartment of Cardiology, MIOT International Hospital, Chennai, India.ORCID 0000-0002-1410-9328
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0001-7657-4383
Tzung-Dau WangCardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.ORCID 0000-0002-7180-3607
Yook-Chin ChiaDepartment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia.ORCID 0000-0003-1995-0359
Narsingh VermaDepartment of Physiology, King George's Medical University, Lucknow, India.ORCID 0000-0003-0348-7419
Yan LiDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-5825-5968
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan.ORCID 0000-0002-8251-4480
Jichi Medical University · JPNational Yang Ming Chiao Tung University · TWRuijin Hospital · CNAtma Jaya Catholic University of Indonesia · IDHue University · VNKing George's Medical University · INMadras Institute of Orthopaedics and Traumatology · INNational Taiwan University Hospital · TWTan Tock Seng Hospital · SGUniversity of Indonesia · IDUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nocturnal home blood pressure (BP) monitoring has been used in clinical practice for ~20 years. The authors recently showed that nocturnal systolic BP (SBP) measured by a home BP monitoring (HBPM) device in a Japanese general practice population was a significant predictor of incident cardiovascular disease (CVD) events, independent of office and morning home SBP levels, and that masked nocturnal hypertension obtained by HBPM (defined as nocturnal home BP ≥ 120/70 mmHg and average morning and evening BP < 135/85 mmHg) was associated with an increased risk of CVD events compared with controlled BP (nocturnal home BP < 120/70 mmHg and average morning and evening BP < 135/85 mmHg). This evidence revealed that (a) it is feasible to use a nocturnal HBPM device for monitoring nocturnal BP levels, and (b) such a device may offer an alternative to ambulatory BP monitoring, which has been the gold standard for the measurement of nocturnal BP. However, many unresolved clinical problems remain, such as the measurement schedule and conditions for the use of nocturnal HBPM. Further investigation of the measurement of nocturnal BP using an HBPM device and assessments of the prognostic value are thus warranted. Asians are at high risk of developing nocturnal hypertension due to high salt sensitivity and salt intake, and the precise management of their nocturnal BP levels is important. Information and communication technology-based monitoring devices are expected to facilitate the management of nocturnal hypertension in Asian populations.

Indexed as

HypertensionMasked HypertensionAsiaBlood PressureBlood Pressure Monitoring, AmbulatoryHumansAsiablood pressureblood pressure monitoringnocturnal home blood pressurenocturnal hypertension

Identifiers

PMID33591641
PMCPMC8029527
OpenAlexW3132820478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.